Evidence map›Paper›PMID 32640101›Full record

ArticleJournal of the International AIDS Society2020

Delays in repeat HIV viral load testing for those with elevated viral loads: a national perspective from South Africa.

Matthew P Fox, Alana T Brennan, Cornelius Nattey, William B MacLeod, Alyssa Harlow, Koleka Mlisana, Mhairi Maskew, Sergio Carmona, Jacob Bor

Open access · goldAbstract read
In one paragraph

Article in Journal of the International AIDS Society, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
0.5field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Matthew P FoxDepartment of Epidemiology, Boston University School of Public Health, Boston, MA, USA.ORCID 0000-0001-9887-0634
Alana T BrennanDepartment of Epidemiology, Boston University School of Public Health, Boston, MA, USA.ORCID 0000-0002-7746-0668
Cornelius NatteyHealth Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
William B MacLeodDepartment of Global Health, Boston University School of Public Health, Boston, MA, USA.
Alyssa HarlowDepartment of Epidemiology, Boston University School of Public Health, Boston, MA, USA.
Koleka MlisanaNational Health Laboratory Service, Johannesburg, South Africa.
Mhairi MaskewHealth Economics and Epidemiology Research Office, Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Sergio CarmonaNational Health Laboratory Service, Johannesburg, South Africa.
Jacob BorDepartment of Epidemiology, Boston University School of Public Health, Boston, MA, USA.ORCID 0000-0002-5112-8536
Boston University · USNational Health Laboratory Service · ZAUniversity of the Witwatersrand · ZA

Funding

Analysis of National Lab Database to evaluate the HIV treatment rollout in South AfricaR01AI115979 · NIAID · WITS HEALTH CONSORTIUM (PTY), LTD · PI FOX, MATTHEW ALEXANDER PEASE, MASKEW, MHAIRI · 2015 to 2019
$1.6M
Evidence of the burden of diabetes, gaps in the diabetes cascade-of-care and the impact of care and treatment on diabetes outcomes in HIV-positive and HIV-negative patients in South AfricaK01DK116929 · NIDDK · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BRENNAN, ALANA TERESA · 2019 to 2023
$866k
Economic, health, and behavioral dimensions of HIV treatment scale-upK01MH105320 · NIMH · BOSTON UNIVERSITY MEDICAL CAMPUS · PI BOR, JACOB · 2015 to 2018
$613k
NIAID NIH HHS 1R01AI115979-01NIAID NIH HHS R01 AI115979NIDDK NIH HHS K01 DK116929NIMH NIH HHS 1K01MH105320-01A1NIMH NIH HHS K01 MH105320
6 · The paper itself

Abstract

introductionIn South Africa, HIV patients with an elevated viral load (VL) should receive repeat VL testing after adherence counselling. We set out to use a national HIV Cohort to describe time to repeat viral load testing across South Africa and identify predictors of time to repeat testing.

methodsWe conducted a cohort study of prospectively collected laboratory data. HIV treatment guidelines have changed over time in South Africa, but call for repeat VL testing within six months if 400 to 1000 copies/mL and two to three months if >1000 copies/mL. We included patients with suppressed viral loads (indicating they are on ART) and a first elevated VL (>400 copies/mL) between April 2004 and December 2014. Follow-up began at first elevated VL and continued until repeat testing, loss to follow-up or December 2016. We calculated adjusted hazard ratios (aHR) using Cox proportional hazard models.

resultsOf 371,648 patients with a VL > 400, 83.9% (311,790) had a repeat VL, in a median (IQR) of 7.0 (4.1 to 12.2) months. Of those with a first viral load 400 to 1000 copies/mL, 56.4% had a repeat VL within guideline recommended six months (defined as up to nine months), whereas among those >1000 copies/mL only 47.7% had a repeat viral load within guideline recommended two to three months (defined as up to six months). We found a small increase in repeat testing associated with higher VL value (aHR 1.11; 95% CI: 1.10 to 1.12 comparing >1000 vs 400 to 1000 copies/mL) and very low CD4 counts at first elevated VL (aHR 1.16; 95% CI: 1.13 to 1.19 comparing CD4 < 50 vs <500 cells/mm

conclusionsMedian time to repeat viral load testing for those with an elevated viral load was longer than guidelines recommend. Future work should identify whether delays are due to patient or provider factors.

Indexed as

Viral LoadAdultCohort StudiesFemaleGuideline AdherenceHIV InfectionsHumansMaleMiddle AgedProportional Hazards ModelsProspective StudiesSerologic TestsSouth AfricaTime FactorsTime-to-TreatmentcohortHIVlaboratory testingmonitoringretentionviral loadviral suppression

Identifiers

PMID32640101
PMCPMC7343337
OpenAlexW3042182359

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.